COVID-19 Treatment: A Review of Early and Emerging Options
Erin K McCreary, PharmD, BCPS, BCIDP, on behalf of the Society of Infectious Diseases Pharmacists, Jason M Pogue, PharmD, BCPS, BCIDP, on behalf of the Society
Erin K McCreary, PharmD, BCPS, BCIDP, on behalf of the Society of Infectious Diseases Pharmacists, Jason M Pogue, PharmD, BCPS, BCIDP, on behalf of the Society
ID Week has partnered with the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) to create a Fellows Exchange Program. Through the program, two…
Health care providers can empower patients to take care of their sexual health
Buddy Creech, MD, MPH, FPIDS, and Febrile creator and infectious diseases physician, Sara Dong, MD, discuss the power of digital education tools on infectious diseases…
Researchers used public health datasets to train machine learning models to predict HIV incidence with high accuracy.
The call for officer and director applications for the IDSA Board of Directors is now open. We are seeking volunteers for the office of Vice…
With regular posts, IDSA’s and HIVMA’s blog reminds readers that infectious diseases don’ t observe national borders, and effective, evidence-based responses protect us all. With…
HIVMA Board member Joseph Cherabie, MD, MSc (@JncherabieMD), provides a front-line perspective on the surge in syphilis cases and shares practical tips for clinicians.
Abstract. Antimicrobial resistance (AMR) affects 2.8 million Americans annually. AMR is identified through antimicrobial susceptibility testing (AST), but
Clinical Practice Innovation Award; D.A. Henderson Award for Outstanding Contributions to Public Health; Alexander Fleming Award for Lifetime Achievement; The Watanakunakorn Clinician Award; The Walter…
Mati Hlatshwayo Davis, MD, MPH, FIDSA discusses the clade I mpox response with guests Jennifer McQuiston, DVM, and Agam Rao, MD, FIDSA of the CDC.